Courtney Crockett

EAGLE AWARD WINNER

NEW HIRE TRAINER

SALES FORCE EFFECTIVE LEADER

• Promote both solid and hematalogic oncology products.
• Launched Zepzelca for Small Cell Lung Cancer
• Promote Vyxeos for secondary AML
• Deliver sales and related objectives against territory targets and contribute to regional and team targets.
• Build customer networks that enable the rapid identification, diagnosis and treatment of patients.
• Assist with removing barriers to access for Jazz products by working with cross-functional colleagues where appropriate.

PRESIDENTS CLUB WINNER

TRIPLE CROWN WINNER

• Educate, communicate, and support the treating clinicians and auxiliary team to ensure our products are utilized in the right patient with the right approach.
• Establish a positive reputation for Lilly Oncology in key academic institutions and leading cancer centers.
• Develop and implement a focused business plan, own the business, build account management plans, and manage/understand the territory

• Drive market share growth and maximize sales performance within the indicated use and approved patient types with Diabetes
• Top 8% of the nation
• Current performance ranking 39/450
• Portfolio performance is 120% of goal
• Current 5x5 growth of 7% in my territory
• National 5x5 growth is 1.8%.

PRESIDENT AWARD WINNER

• Marketed a newly FDA approved orphan injectable to specialists in Women's Health an assigned territory.
• Consistently ranked 2/10 in total Rx sales since product launch in February 2011
• Developed and implemented territory business plans centered on performance and execution impact.

• Maximize sales growth for on targeted physicians including pain management, neurologists, psychiatrists and PCP’s promoting products that treat neuropathy, arthritis and major depressive disorder including Celebrex.

• Maximized sales and market share growth on targeted medical Allergist, oncologists, Neurologists, radiation oncologists, hematologists, neurosurgeons, pain management & specialty pharmacists
• Increased revenue by 20%.
• Worked directly with patient assistance, “buy and bill”, and managed care administrators to assist patients with funding and support for their condition
• Successfully sold oral and injectable medications including Temodar, Intron-A and Noxifil for primary brain tumors, malignant melanoma and prophylaxis for Candida and aspergillus to physicians and teaching hospitals.
• Developed and implemented territory business plans centered on performance and execution impact that properly identify and prioritize activities to accomplish short and long term business goals.
• Attended tumor boards and grand rounds in order to maximize customer relationships.